Pages that link to "Item:Q4665959"
From MaRDI portal
The following pages link to Sample Size Determination for Phase II Clinical Trials Based on Bayesian Decision Theory (Q4665959):
Displaying 10 items.
- Meta-analytic-predictive use of historical variance data for the design and analysis of clinical trials (Q1658139) (← links)
- A Bayesian Decision Approach for Sample Size Determination in Phase II Trials (Q3078735) (← links)
- Decision-Theoretic Designs for Pre-Phase II Screening Trials in Oncology (Q3078865) (← links)
- Decision-Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies (Q3079128) (← links)
- Bayesian approach to determine the number of subsequent users of a new treatment (Q3435346) (← links)
- Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes (Q4666685) (← links)
- Optimizing sample size in relative bioavailability trials using a Bayesian decision-theoretic framework (Q4964398) (← links)
- Bayesian adaptive two-stage design for determining person-time in Phase II clinical trials with Poisson data (Q5138112) (← links)
- Determination of the optimal sample size for a clinical trial accounting for the population size (Q5280174) (← links)
- Bayesian designs with frequentist and Bayesian error rate considerations (Q5424966) (← links)
